Navigation Links
Characterizing Skin Cancer by Microarrays

Microarray technology can be used to identify each stage of skin cancer tumor (melanoma) progression, according to a newly published report.

Melanomas grow in two phases: radial and vertical. Vertical-phase tumors are more likely to metastasize (spread cancer to other parts of the body) than radial melanomas.

Christopher Haqq and colleagues dissected a large primary melanoma into radial and vertical portions, and through microarray techniques found that, in the transition from radial to vertical growth, the melanomas lost the expression of certain molecules, resulting in increased risk of metastasis.

However, some metastatic tumors retained a gene expression pattern characteristic of the radial growth phase, which implies that both radial and vertical melanomas can metastasize. The authors identified over 2,000 genes that distinguished the stages of melanoma progression.

The authors say that their results will provide a basis for developing new molecular diagnostic techniques and, eventually, targeted therapies for patients with skin cancer.

PNAS is the multi-disciplinary, peer-reviewed journal of the National Academy of Sciences. Founded in 1914, PNAS publishes daily online and weekly in print. The preceding highlights are not intended to substitute for articles as sources of information. The articles in PNAS report original research by independent authors and do not necessarily represent the views of the National Academy of Sciences or the National Research Council.


'"/>

Source:PNAS


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Jump-starting T Cells In Skin Cancer
3. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
8. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
9. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
10. New Breast Cancer Test Could Save Lives
11. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... ... September 19, 2017 , ... The new and improved ... The pocket testers even stand upright with a new cap design that is versatile, ... in the field who need to test water quality. , The Oakton pocket testers ...
(Date:9/19/2017)... ... September 19, 2017 , ... Avomeen ... the recipients of its 2017 Science Student Award. The scholarship program is dedicated ... with community service defray the costs of obtaining their science education. , Avomeen ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... band technologies for surgical applications, announced today that two new patents have been ... Michael Albert, MD, Co-Founder of Band-LOK, said, “We continue to explore additional clinically-relevant ...
(Date:9/18/2017)... Sept. 18, 2017   Montrium , a growing leader in ... new partnership with a groundbreaking non-profit research organization, Multidisciplinary Association ... ... studies for PTSD ... granted Breakthrough Therapy Designation to MDMA for the treatment of Posttraumatic ...
Breaking Biology Technology: